The U.S. reprocessed medical devices market size is anticipated to reach USD 3.09 billion by 2030 and is anticipated to expand at a CAGR of 16.3% during the forecast period. Many single-use devices are expensive and reprocessing them can help hospitals and healthcare facilities save a considerable amount of money. Reputable reprocess brands, such as Innovative Health and Stryker, adhere to strict quality control standards and regulatory requirements. Strict guidelines and standards are in place to ensure that reprocessed devices meet the same quality and safety requirements as new ones. This allows patients to receive high-quality care without the need to use new, potentially more expensive devices.
The increasing usage of these reprocessed medical devices over the newer ones every time leads to saving resources and cutting costs. For instance, as per the information published by the Association of Medical Device Reprocessors (AMDR), maximizing the use of reprocessed single-use medical devices can help hospitals in the U.S. to save approximately USD 2.28 billion annually.
To protect patient safety and preserve device efficacy, reprocessed medical devices need to go through stringent quality control and sterilizing procedures. The FDA oversees guaranteeing the efficacy, safety, and quality of medical devices, including ones that have undergone reprocessing. Reprocessed medical devices are classified as "single-use devices" since they have been sanitized, cleaned, and packed for further use. Under the Federal Food, Drug, and Cosmetic Act's Medical Device Amendments, the FDA oversees regulating these devices. Before putting their devices on the market, manufacturers of reprocessed devices have to get FDA clearance or approval and adhere to certain quality system requirements.
This product will be delivered within 1-3 business days.
The increasing usage of these reprocessed medical devices over the newer ones every time leads to saving resources and cutting costs. For instance, as per the information published by the Association of Medical Device Reprocessors (AMDR), maximizing the use of reprocessed single-use medical devices can help hospitals in the U.S. to save approximately USD 2.28 billion annually.
To protect patient safety and preserve device efficacy, reprocessed medical devices need to go through stringent quality control and sterilizing procedures. The FDA oversees guaranteeing the efficacy, safety, and quality of medical devices, including ones that have undergone reprocessing. Reprocessed medical devices are classified as "single-use devices" since they have been sanitized, cleaned, and packed for further use. Under the Federal Food, Drug, and Cosmetic Act's Medical Device Amendments, the FDA oversees regulating these devices. Before putting their devices on the market, manufacturers of reprocessed devices have to get FDA clearance or approval and adhere to certain quality system requirements.
U.S. Reprocessed Medical Devices Market Report Highlights
- The cardiovascular segment dominated the product segment with 56.5% share in 2023 and is expected to grow at the fastest CAGR over the forecast period. This high prevalence leads to a significant demand for medical devices used in cardiovascular treatments and diagnostics, which, in turn, creates demand for reprocessed medical devices
- The 3rd party reprocessing segment held the largest market share in 2023. Third-party reprocessing companies offer cost-effective solutions for reprocessing medical devices
- Hospitals dominated the end-use segment in 2023. Hospitals and healthcare facilities use reprocessed medical devices as they offer significant cost savings compared to purchasing new, single-use devices
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Reprocessed Medical Devices Market Variables, Trends & Scope
Chapter 4. U.S. Reprocessed Medical Devices Market: Product Type Estimates & Trend Analysis
Chapter 5. U.S. Reprocessed Medical Devices Market: Type Estimates & Trend Analysis
Chapter 6. U.S. Reprocessed Medical Devices Market: End-use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Stryker
- Innovative Health
- NEScientific, Inc.
- Medline Industries, Inc.
- Arjo
- Vanguard AG
- Cardinal Health
- SureTek Medical
- Soma Tech Medical
- Johnson & Johnson Services, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.08 Billion |
| Forecasted Market Value ( USD | $ 3.09 Billion |
| Compound Annual Growth Rate | 16.3% |
| Regions Covered | United States |
| No. of Companies Mentioned | 10 |
